Home/Publication/LYFE to Lead in Healthcare Play
LYFE to Lead in Healthcare Play 

30 Aug 2024

US$ 19.00

LYFE Capital is taking a leading role in the issuance of US$200 million US dollar-denominated European convertible...

Price / article: US$19.00
OR existing subscriber
Related Publications

Headline Asia announced the final closing of Headline Asia V LP (Asia V) at US$145 m. The new fund attracted ......

The Carlyle Group Inc, through its Carlyle Global Infrastructure, has launched Revera Energy, a clean energy ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.